Advanced search
Publication Cover
Hematology Volume 27, 2022 - Issue 1
Submit an article Journal homepage
4,372
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Efficacy and toxicity of SEAM (semustine, etoposide, cytarabine, and melphalan) conditioning regimen followed by autologous stem cell transplantation in lymphoma

Lihong Zhanga First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, Jiangsu, People’s Republic of China;b First Affiliated Hospital of Soochow University, Department of Ultrasound, Suzhou, Jiangsu, People’s Republic of China;c Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health, Suzhou, Jiangsu, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-8565-6775View further author information
ORCID Icon,
Haifei Yanga First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, Jiangsu, People’s Republic of China;c Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health, Suzhou, Jiangsu, People’s Republic of ChinaView further author information
,
Chongsheng Qiana First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, Jiangsu, People’s Republic of China;c Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health, Suzhou, Jiangsu, People’s Republic of ChinaView further author information
,
Jihao Zhoud The Second Clinical Medical College (Shenzhen People’s Hospital), Jinan University, Department of Hematology, Shenzhen, Guangdong, People’s Republic of ChinaView further author information
,
Qian Zhua First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, Jiangsu, People’s Republic of China;c Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health, Suzhou, Jiangsu, People’s Republic of ChinaView further author information
,
Yibin Jianga First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, Jiangsu, People’s Republic of China;c Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health, Suzhou, Jiangsu, People’s Republic of ChinaView further author information
,
Shuo Liua First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, Jiangsu, People’s Republic of China;c Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health, Suzhou, Jiangsu, People’s Republic of ChinaView further author information
,
Xiaochen Chena First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, Jiangsu, People’s Republic of China;c Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health, Suzhou, Jiangsu, People’s Republic of ChinaView further author information
,
Ting Xua First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, Jiangsu, People’s Republic of China;c Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health, Suzhou, Jiangsu, People’s Republic of ChinaView further author information
,
Changju Qua First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, Jiangsu, People’s Republic of China;c Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health, Suzhou, Jiangsu, People’s Republic of ChinaView further author information
,
Caixia Lia First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, Jiangsu, People’s Republic of China;c Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health, Suzhou, Jiangsu, People’s Republic of ChinaView further author information
,
Zhengming Jina First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, Jiangsu, People’s Republic of China;c Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health, Suzhou, Jiangsu, People’s Republic of ChinaView further author information
,
Jianhong Chue Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, Jiangsu, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Xinyou Zhangd The Second Clinical Medical College (Shenzhen People’s Hospital), Jinan University, Department of Hematology, Shenzhen, Guangdong, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Depei Wua First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, Jiangsu, People’s Republic of China;c Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health, Suzhou, Jiangsu, People’s Republic of China;e Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, Jiangsu, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Haiwen Huanga First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou, Jiangsu, People’s Republic of China;c Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health, Suzhou, Jiangsu, People’s Republic of China;e Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, Jiangsu, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 404-411 | Published online: 12 Apr 2022

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Meng Lin, Xiaolong Wu, Lei Zhang, Ling Li, Xinhua Wang, Xiaorui Fu, Zhenchang Sun, Xudong Zhang, Linan Zhu, Hui Yu, Yu Chang, Feifei Nan, Jiaqin Yan, Zhiyuan Zhou, Cunzhen Shi, Mingzhi Zhang & Xin Li. (2023) Fotemustine, etoposide, cytarabine, and cyclophosphamide (FEAC) conditioning regimen for autologous stem cell transplantation in lymphoma. Leukemia & Lymphoma 64:3, pages 605-612.
Read now

Articles from other publishers (1)

. (2022) Multiple drugs. Reactions Weekly 1905:1, pages 336-336.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.